Work

Effects of hyperoxia on pulmonary inflammation and organ injury in a human in vivo model (HIPI): a randomised controlled trial

Year: 2026
Type: article
Abstract: INTRODUCTION: It is uncertain whether hyperoxia contributes to adverse intensive care unit outcomes. Potential harm is likely mediated by oxidative stress driving pulmonary and systemic inflammation. METHODS: 1.0, 60 L/min) or synthetic medical air for 6 hours. Bronchoalveolar lavage (BAL) was performed at 6 hours following inhalation of 50 µg of LPS. Blood was collected at baseline, 6 hours and 24 hours. The primary outcome was BAL interleukin-8 (IL-8). Secondary outcome measures included markers of pulmonary and systemic inflammation. Untargeted metabolomic and lipidomic profiling of BAL fluid and plasma was performed by liquid chromatography-mass spectrometry to investigate oxidative stress. Transcriptomic analysis was also performed on whole blood. RESULTS: Between January 2023 and March 2024, twenty-two participants were recruited and completed all study procedures. BAL IL-8 did not differ between groups at 6 hours (hyperoxia 375.7 pg/mL (IQR 351.1-467.7) vs placebo 331.9 pg/mL (IQR 251.6-459), p=0.33). No between-group differences were observed in BAL cytokines or markers of systemic inflammation. Hyperoxia was associated with an approximately fourfold increase in BAL reduced glutathione (unadjusted p=0.02). Hyperoxia was associated with distinct transcriptional responses at 24 hours with 175 differentially expressed genes (padj <0.05), including upregulation of genes related to extracellular matrix remodelling, platelet activation and endothelial repair. DISCUSSION: In a human inhaled LPS challenge model, 6 hours of hyperoxia did not increase markers of pulmonary or systemic inflammation. TRIAL REGISTRATION NUMBER: NCT05414370.
Source: Thorax
Language: English
Field: Medicine
Open Access status: hybrid
OpenAlex ID: W7212107916
FWCI:
Cites: 29
Cited by:
Related to: